Immunohistochemistry has shown increased staining of IFNβ, as well as IFN responsive genes such as MxA in dermatomyositis skin, and this higher level of expression can differentiate DM from other inflammatory skin diseases such as eczema [58, 59]. The gene discussed is MX1; the disease is dermatomyositis.